<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncolo...

    Spectrum Pharmaceuticals is a leading biotechno...

    Filing Type:    PU
    Akebia Therapeutics, Inc.

    Akebia Therapeutics, Inc.

    We are a fully integrated biopharmaceutical company focused on the development and...

    We are a fully integrated biopharmaceutical com...

    Filing Type:    PU
    Cesca Therapeutics Inc.

    Cesca Therapeutics Inc.

    Cesca is a leading regenerative medicine company that develops, commercializes and...

    Cesca is a leading regenerative medicine compan...

    Filing Type:    PU
    Astellas Pharma, Inc.

    Astellas Pharma, Inc.

    Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fiel...

    Astellas Pharma Inc. is a pharmaceutical compan...

    Filing Type:    PU
    Sensus Healthcare, Inc.

    Sensus Healthcare, Inc.

    Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW) is a medical device company that is ...

    Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW) i...

    Filing Type:    PU
    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics, Inc.

    Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental...

    Pluristem Therapeutics Inc. is a clinical-stage...

    Filing Type:    PU
    PDS Biotechnology Corporation

    PDS Biotechnology Corporation

    PDS Biotechnology has a growing pipeline of clinical-stage immunotherapies to trea...

    PDS Biotechnology has a growing pipeline of cli...

    Filing Type:    PU
    Immuron Limited

    Immuron Limited

    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on o...

    Immuron Ltd is a publicly listed Australian bio...

    Filing Type:    PU
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Galectin Therapeutics Inc.

    Galectin Therapeutics Inc.

    Galectin Therapeutics is a biotechnology company focused on discovery and developm...

    Galectin Therapeutics is a biotechnology compan...

    Filing Type:    PU
    Champions Oncology, Inc.

    Champions Oncology, Inc.

    Champions Oncology, Inc. is engaged in the development of advanced technology solu...

    Champions Oncology, Inc. is engaged in the deve...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.